444 related articles for article (PubMed ID: 23738515)
21. X-chromosomal inactivation analysis of uterine leiomyomas reveals a common clonal origin of different tumor nodules in some multiple leiomyomas.
Cai YR; Diao XL; Wang SF; Zhang W; Zhang HT; Su Q
Int J Oncol; 2007 Dec; 31(6):1379-89. PubMed ID: 17982665
[TBL] [Abstract][Full Text] [Related]
22. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
23. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
[TBL] [Abstract][Full Text] [Related]
25. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
[TBL] [Abstract][Full Text] [Related]
26. Parity associates with chromosomal damage in uterine leiomyomas.
Kuisma H; Bramante S; Rajamäki K; Sipilä LJ; Kaasinen E; Kaukomaa J; Palin K; Mäkinen N; Sjöberg J; Sarvilinna N; Taipale J; Kauppi L; Tumiati M; Hassinen A; Pitkäniemi J; Jalkanen J; Heikkinen S; Pasanen A; Heikinheimo O; Bützow R; Välimäki N; Aaltonen LA
Nat Commun; 2021 Sep; 12(1):5448. PubMed ID: 34521855
[TBL] [Abstract][Full Text] [Related]
27. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.
Barker KT; Spendlove HE; Banu NS; Bridge JA; Fisher C; Shipley J; Garrett M; Manyonda I; Houlston RS
Cancer Lett; 2006 Apr; 235(1):136-40. PubMed ID: 15949892
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
Je EM; Kim MR; Min KO; Yoo NJ; Lee SH
Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225
[TBL] [Abstract][Full Text] [Related]
29. Uterine leiomyoma cytogenetics.
Nibert M; Heim S
Genes Chromosomes Cancer; 1990 May; 2(1):3-13. PubMed ID: 2278965
[TBL] [Abstract][Full Text] [Related]
30. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
[TBL] [Abstract][Full Text] [Related]
31. Med12 gain-of-function mutation causes leiomyomas and genomic instability.
Mittal P; Shin YH; Yatsenko SA; Castro CA; Surti U; Rajkovic A
J Clin Invest; 2015 Aug; 125(8):3280-4. PubMed ID: 26193636
[TBL] [Abstract][Full Text] [Related]
32. Uterine leiomyomas: cytogenetic and histologic profile.
Meloni AM; Surti U; Contento AM; Davare J; Sandberg AA
Obstet Gynecol; 1992 Aug; 80(2):209-17. PubMed ID: 1635734
[TBL] [Abstract][Full Text] [Related]
33. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients.
Sadeghi S; Khorrami M; Amin-Beidokhti M; Abbasi M; Kamalian Z; Irani S; Omrani M; Azmoodeh O; Mirfakhraie R
Tumour Biol; 2016 Feb; 37(2):1567-71. PubMed ID: 26298726
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetics of multiple uterine leiomyomas, parametrial leiomyoma and disseminated peritoneal leiomyomatosis.
Mark J; Havel G; Dahlenfors R; Wedell B
Anticancer Res; 1991; 11(1):33-9. PubMed ID: 2018368
[TBL] [Abstract][Full Text] [Related]
35. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
Alam NA; Olpin S; Leigh IM
Br J Dermatol; 2005 Jul; 153(1):11-7. PubMed ID: 16029320
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
[TBL] [Abstract][Full Text] [Related]
37. Complex chromosome rearrangements involving 12q14 in two uterine leiomyomas.
Pandis N; Bardi G; Sfikas K; Panayotopoulos N; Tserkezoglou A; Fotiou S
Cancer Genet Cytogenet; 1990 Oct; 49(1):51-6. PubMed ID: 2397473
[TBL] [Abstract][Full Text] [Related]
38. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.
Packenham JP; du Manoir S; Schrock E; Risinger JI; Dixon D; Denz DN; Evans JA; Berchuck A; Barrett JC; Devereux TR; Ried T
Mol Carcinog; 1997 Aug; 19(4):273-9. PubMed ID: 9290705
[TBL] [Abstract][Full Text] [Related]
39. Classical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas.
Tai CT; Lin WC; Chang WC; Chiu TH; Chen GT
Mol Reprod Dev; 2003 Feb; 64(2):172-8. PubMed ID: 12506349
[TBL] [Abstract][Full Text] [Related]
40. Differential gene expression in uterine leiomyoma.
Skubitz KM; Skubitz AP
J Lab Clin Med; 2003 May; 141(5):297-308. PubMed ID: 12761473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]